Indian eye hospital chain Dr. Agarwal’s Health Care has raised $80 million from existing investors Singapore-based Temasek and US-based TPG
Indian eye hospital chain Dr. Agarwal’s Health Care has raised $80 million from existing investors Singapore-based Temasek and US-based TPG
The fundraising will provide significant capital to drive the company’s expansion plans. The company plans to deploy capital to expand its current network of 150+ centers to more than 300+ centers in the next 3 years. The company has new projects under development in Mumbai, Punjab, central and north India, among others. The company continues to achieve growth and success in its key markets including Tamil Nadu, Karnataka, Maharashtra, Gujarat, Punjab, Telangana, Andhra Pradesh, Kerala and West Bengal.
The fundraising will provide significant capital to drive the company’s expansion plans. The company plans to deploy capital to expand its current network of 150+ centers to more than 300+ centers in the next 3 years. The company has new projects under development in Mumbai, Punjab, central and north India, among others. The company continues to achieve growth and success in its key markets including Tamil Nadu, Karnataka, Maharashtra, Gujarat, Punjab, Telangana, Andhra Pradesh, Kerala and West Bengal.
Along with network expansion, the company will also invest in advanced technologies for vision correction such as SMILE, Laser Cataract Surgery, and for advanced technologies for treating Vitreo-retinal diseases such as Diabetic Retinopathy and age-related macular degeneration.
Along with network expansion, the company will also invest in advanced technologies for vision correction such as SMILE, Laser Cataract Surgery, and for advanced technologies for treating Vitreo-retinal diseases such as Diabetic Retinopathy and age-related macular degeneration.
Dr. Eye Hospital Stock Agarwal rose as much as 10.3% after the announcement, before trimming some of the gains to last trade up 4.2%.
Dr. Eye Hospital Stock Agarwal rose as much as 10.3% after the announcement, before trimming some of the gains to last trade up 4.2%.
Dr. best practices from various sectors while relying on continuous innovation and cutting-edge technology to serve our patients. This new investment will be used to expand our footprint in India and Internationally, along with acquiring the latest technologies for super-specialized eye care.”
Dr. best practices from various sectors while relying on continuous innovation and cutting-edge technology to serve our patients. This new investment will be used to expand our footprint in India and Internationally, along with acquiring the latest technologies for super-specialized eye care.”
“We continue to be passionate about the company’s growth potential and share the company’s vision to deliver world-class clinical results along with convincing financial performance. Dr. Agarwal’s has the potential to become a global leader in the eye care segment,” said Ankur Thadani, Business Unit Partner at TPG Growth.
“We continue to be passionate about the company’s growth potential and share the company’s vision to deliver world-class clinical results along with convincing financial performance. Dr. Agarwal’s has the potential to become a global leader in the eye care segment,” said Ankur Thadani, Business Unit Partner at TPG Growth.
Dr. Adil Agarwal, CEO, Dr. Agarwal’s Group of Eye Hospitals added, “The investment will be used to support the business through its next phase of growth, including the acquisition of small hospitals and our network and new field expansions of our network. We are looking to double our network in the next 3 years and are also looking to expand aggressively in Maharashtra, Punjab, Delhi, Uttar Pradesh and central India apart from penetrating deeper into our existing markets. We will also build more than 100 primary eye clinics in tier 2 and 3 cities in the coming years. Africa is another important geography for us. We have a network of 15 hospitals, and we will deepen our presence in Kenya, Zambia and Tanzania and work towards adding 10 more centers in these countries.”
Dr. Adil Agarwal, CEO, Dr. Agarwal’s Group of Eye Hospitals added, “The investment will be used to support the business through its next phase of growth, including the acquisition of small hospitals and our network and new field expansions of our network. We are looking to double our network in the next 3 years and are also looking to expand aggressively in Maharashtra, Punjab, Delhi, Uttar Pradesh and central India apart from penetrating deeper into our existing markets. We will also build more than 100 primary eye clinics in tier 2 and 3 cities in the coming years. Africa is another important geography for us. We have a network of 15 hospitals, and we will deepen our presence in Kenya, Zambia and Tanzania and work towards adding 10 more centers in these countries.”
Veda Corporate Advisors are financial advisers to Dr. Agarwal’s Health Care Ltd. in this transaction.
Veda Corporate Advisors are financial advisers to Dr. Agarwal’s Health Care Ltd. in this transaction.
Dr. Eye Hospital Group Agarwal started as a single facility in Chennai in 1957. The group was led by Chief Prof. (Dr.) Amar Agarwal. He is a pioneer in the field of eye care, known for several breakthrough surgical innovations such as Glued IOL, PDEK, and PhakoNit. Dr. Eye Hospital Agarwal now has a total network of 151 centers (140 hospitals and 11 eye clinics) spread across India and Africa. The Group’s presence spans 10 countries and more than 14 states in India
Dr. Eye Hospital Group Agarwal started as a single facility in Chennai in 1957. The group was led by Chief Prof. (Dr.) Amar Agarwal. He is a pioneer in the field of eye care, known for several breakthrough surgical innovations such as Glued IOL, PDEK, and PhakoNit. Dr. Eye Hospital Agarwal now has a total network of 151 centers (140 hospitals and 11 eye clinics) spread across India and Africa. The Group’s presence spans 10 countries and more than 14 states in India
#Indian #eye #hospital #network #Agarwals #raised #million #TPG #Temasek
